down arrow

Marksans Pharma

44
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE750C01026
  • NSEID: MARKSANS
  • BSEID: 524404
INR
204.05
9.55 (4.91%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 14.67 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
2,177.00
1,852.00
1,490.00
1,376.00
1,134.00
1,000.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,177.00
1,852.00
1,490.00
1,376.00
1,134.00
1,000.00
Expenditure (Ex Depriciation)
Stock Adjustments
-73.00
-6.00
12.00
-136.00
52.00
-19.00
Raw Materials Consumed
1,111.00
927.00
703.00
731.00
514.00
517.00
Power & Fuel Cost
36.00
24.00
18.00
16.00
14.00
13.00
Employee Cost
293.00
239.00
220.00
197.00
168.00
159.00
Operating Expenses
87.00
55.00
12.00
34.00
32.00
49.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
127.00
133.00
119.00
109.00
79.00
66.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
26.00
45.00
115.00
39.00
39.00
37.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,718.00
1,512.00
1,231.00
1,036.00
941.00
867.00
Operating Profit (PBDIT) excl Other Income
458.00
339.00
258.00
339.00
192.00
132.00
Other Income
50.00
59.00
41.00
6.00
0.00
4.00
Operating Profit (PBDIT)
508.00
398.00
300.00
346.00
192.00
136.00
Interest
11.00
9.00
8.00
7.00
8.00
9.00
Profit before Depriciation and Tax
497.00
389.00
292.00
338.00
183.00
127.00
Depreciation
74.00
51.00
44.00
36.00
26.00
22.00
Profit Before Taxation & Exceptional Items
423.00
337.00
247.00
302.00
157.00
104.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
423.00
337.00
247.00
302.00
157.00
104.00
Provision for Tax
108.00
72.00
60.00
63.00
36.00
23.00
Profit After Tax
314.00
265.00
186.00
238.00
120.00
80.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
777.00
509.00
334.00
85.00
2.00
-69.00
Profit Available for appropriations
1,091.00
775.00
519.00
321.00
123.00
7.00
Appropriations
1,091.00
775.00
519.00
321.00
123.00
7.00
Equity Dividend (%)
60.00%
50.00%
25.00%
25.00%
10.00%
5.00%
Earnings Per Share
6.92
6.41
4.51
5.76
2.95
1.87
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 17.56% vs 24.23% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 35.15% vs 31.07% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 22.73% vs 8.07% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 18.68% vs 42.02% in Mar 2023

Compare Profit and Loss Results of Marksans Pharma
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,177.00
10,334.00
-8,157.00
-78.93%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,177.00
10,334.00
-8,157.00
-78.93%
Expenditure (Ex Depriciation)
Stock Adjustments
-73.00
-94.00
21.00
22.34%
Raw Materials Consumed
1,111.00
3,263.00
-2,152.00
-65.95%
Power & Fuel Cost
36.00
129.00
-93.00
-72.09%
Employee Cost
293.00
2,274.00
-1,981.00
-87.12%
Operating Expenses
87.00
210.00
-123.00
-58.57%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
127.00
928.00
-801.00
-86.31%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
26.00
134.00
-108.00
-80.60%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,718.00
7,798.00
-6,080.00
-77.97%
Operating Profit (PBDIT) excl Other Income
458.00
2,536.00
-2,078.00
-81.94%
Other Income
50.00
280.00
-230.00
-82.14%
Operating Profit (PBDIT)
508.00
2,817.00
-2,309.00
-81.97%
Interest
11.00
35.00
-24.00
-68.57%
Profit before Depriciation and Tax
497.00
2,782.00
-2,285.00
-82.14%
Depreciation
74.00
398.00
-324.00
-81.41%
Profit Before Taxation & Exceptional Items
423.00
2,384.00
-1,961.00
-82.26%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
423.00
2,399.00
-1,976.00
-82.37%
Provision for Tax
108.00
457.00
-349.00
-76.37%
Profit After Tax
314.00
1,926.00
-1,612.00
-83.70%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
777.00
8,012.00
-7,235.00
-90.30%
Profit Available for appropriations
1,091.00
9,925.00
-8,834.00
-89.01%
Appropriations
1,091.00
9,925.00
-8,834.00
-89.01%
Equity Dividend (%)
60%
0%
60.00
Earnings Per Share
6.92
47.75
-40.83
-85.51%
Profit And Loss - Net Sales
Net Sales 2,177.41 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 17.56% vs 24.23% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 458.58 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 35.15% vs 31.07% in Mar 2023

Profit And Loss - Interest
Interest 11.20 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 22.73% vs 8.07% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 314.89 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 18.68% vs 42.02% in Mar 2023